SCHEMBL23611530

SCHEMBL23611530

COCCN(CCOC)c1ccc(N=O)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP1B1 Q16678 1/20 0.37
MAPT P10636 5/20 0.36
KDM4E B2RXH2 2/20 0.36
GFER P55789 2/20 0.34
SLC16A3 O15427 2/20 0.34
SLC16A1 P53985 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MAPK1 P28482 1/20 0.34
HPGD P15428 2/20 0.34
CYP3A4 P08684 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CRHR1 P34998 3/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30817926 1.00 ALDH1A1 (0.43) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
SCHEMBL24855995 0.93 ALDH1A1 (0.39) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
SCHEMBL24855527 0.87 ALDH1A1 (0.36) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
SCHEMBL29752123 0.85 ALDH1A1 (0.43) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
SCHEMBL179136 0.85 ALDH1A1 (0.43) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
SCHEMBL29914670 0.84 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTKDM4EGFER
SCHEMBL11188554 0.84 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTKDM4EGFER
Hydrochloric Acid SCHEMBL564874 0.84 ALDH1A1 (0.42) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
Hydrochloric Acid SCHEMBL29361270 0.84 ALDH1A1 (0.42) ALDH1A1L3MBTL1CYP1B1MAPTKDM4E
Hydrochloric Acid SCHEMBL11766454 0.83 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPTKDM4EGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360088-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-10-31 US disclosed
EP-4367104-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING Oregon Health & Science University (US) 2024-05-15 EP disclosed
US-20230098686-A1 NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION UNIV OREGON HEALTH & SCIENCE (US) 2023-03-30 US disclosed
US-20230098686-A1 NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION UNIV OREGON HEALTH & SCIENCE (US) 2023-03-30 US disclosed
US-20230098438-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-03-30 US disclosed
WO-2023278874-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-01-05 WO disclosed
WO-2023278874-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-01-05 WO disclosed
EP-4084829-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING Oregon Health & Science University (US) 2022-11-09 EP disclosed
WO-2021158820-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-12 WO disclosed
WO-2021158820-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-12 WO disclosed
WO-2021138116-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-07-08 WO disclosed
WO-2021138116-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230098438-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING GAP43, NTRK1, MAG ALDH1A1 861/4885L3MBTL1 2295/4885CYP1B1 3921/4885
US-20230098686-A1 NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION PFAS, NPFFR2, NPFFR1 ALDH1A1 556/4885L3MBTL1 4234/4885CYP1B1 652/4885
US-20240360088-A1 WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING PAX8, GAP43, PAX2 ALDH1A1 1457/4885L3MBTL1 1729/4885CYP1B1 1743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.